Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 2018: Treatment Strategies for Cardiometabolic Diseases
Author(s): Carolyn Lam , Subodh Verma Added: 5 years ago
Prof Carolyn Lam (National Heart Center, SG) & Prof Subodh Verma (St. Michael's Hospital, Toronto, CA) discusses treatment strategies for cardiometabolic diseases - The role of antidiabetic medicines. Filmed by Radcliffe Cardiology on site at AHA 2018. This peer-to-peer discussion was funded by an unrestricted grant by Novo Nordisk. View more

Prevention & Chronic Conditions
ESC 2018: Use of SGLT2 inhibitors in clinical practice to reduce CV mortality in patients with type 2 diabetes
Author(s): Javed Butler , Stefan Anker Added: 5 years ago
Esc 2018: Use of sglt2 Inhibitors in Clinical Practice to Reduce CV Mortality in Patients With Type 2 Diabetes - Prof Javed Butler & Prof Stefan Anker Filmed on-site at ESC 2018 by Radcliffe Cardiology. View more

Prevention & Chronic Conditions
Thomas Jared Bunch
Job title: Head Of Section - Heart Rhythm Services
Personal History A native of Logan Utah , Dr Thomas Jared Bunch is an Electrophysiologist focused on heart rhythms.2 He is an avid sports fan particularly devoted to his alma mater. He enjoys long distance running, endurance training, community work with youth organizations and mentoring young clinical investigators.5 Academic History Dr Bunch got his BA from Utah State University… View more
David Fitchett
Job title: Associate Professor of Medicine
Dr David Fitchett graduated from Cambridge University in 1970, and continued his clinical training at the Middlesex Hospital, London. In 1978 he moved to the Royal Victoria Hospital, Montreal where he was director of the CCU for more than 10 years, and medical director of the cardiac transplant program.In 1997, he came to St Michael’s Hospital in Toronto as Director of the Cardiac ICU. Dr… View more
Martin Maresch
Job title: Senior Consultant Vascular and Endovascular Surgeon
Dr Martin Maresch is a Senior Consultant Vascular & Endovascular Surgeon at Bahrain Defence Force - Royal Medical Services Hospital, Bahrain. Established fully functioning Vascular Centre from the scratch, able to co-ordiante the team to push for the best outcome. Special interest in Medical Education, Reaserch and Teaching recently within RCSI Bahrain. Senior Consultant of Vascular &… View more
ESC 2021 Discussion: The FIGARO-DKD Trial
Author(s): Bertram Pitt , Harriette Van Spall Added: 2 years ago
Late-breaker host, Dr Harriette Van Spall (McMaster University, CA)is joined by Principal Investigator, Dr Bertram Pitt (University of Michigan, US) for an insightful discussion on the FIGARO-DKD Trial presented at ESC Congress 2021. The aim of study was to asses whether finerenone (Bayer), nonsteroidal mineralocorticoid receptor antagonist (MRA), in addition to standard daily therapy, is… View more

Prevention & Chronic Conditions

CV Disease in Special Populations
AHA 22 Late-Breaker Discussion: The DCP Trial
Author(s): Areef Ishani , Harriette Van Spall Added: 1 year ago
AHA 2022 — Late-breaker Host, Dr Harriette Van Spall (McMaster University, CA) met investigator, Dr Areef Ishani (Minneapolis VA Health Care System, US)to discuss the The Diuretic Comparison Project (DCP) (NCT02185417). The aim of this study was to compare two thiazide-type diuretics, chlorthalidone and hydrochlorothiazide in 13523 patients over age 65 with hypertension. Published in The New… View more

Prevention & Chronic Conditions
AHA 2018: The Latest Updates on CVOT Data for Type 2 DM Therapies
Author(s): John JV McMurray , Carolyn Lam Added: 5 years ago
Prof Carolyn Lam (National Heart Center, SG) & Prof John McMurray (University of Glasgow, UK) discuss the latest updates on CVOT data for Type 2 DM therapies. Filmed by Radcliffe Cardiology on site at AHA 2018. This peer-to-peer discussion was funded by an unrestricted grant by Novo Nordisk. View more

Prevention & Chronic Conditions
ESC 2020: Commentary on the DAPA-CKD Study — Dr Giuseppe Galati
Author(s): Giuseppe Galati Added: 3 years ago
Dr Giuseppe Galati (San Raffaele Scientific Institute, Milan, IT) discusses the DAPA-CKD study that was presented at ESC 2020. This study evaluated the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease. Recorded remotely from Milan, 2020. Recording Editor: Natascha Wienand Editor: Mirjam Boros View more

Prevention & Chronic Conditions
AHA 2023 CardioNerds Conference Scholars Late-Breaking Video Collection
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 5 months ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more

Vascular Disease and Surgery

Heart Failure